Group One Trading’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.01K Buy
1,400
+400
+40% +$2.3K ﹤0.01% 6533
2026
Q1
$6.28K Buy
+1,000
New +$9.29K ﹤0.01% 6609
2025
Q4
Sell
-2,400
Closed -$49.2K 8873
2025
Q3
$49.2K Buy
+2,400
New +$38.1K ﹤0.01% 5977
2025
Q2
Sell
-45,300
Closed -$392K 8456
2025
Q1
$392K Buy
45,300
+21,600
+91% +$132K ﹤0.01% 3339
2024
Q4
$115K Buy
+23,700
New +$132K ﹤0.01% 4391
2023
Q3
Sell
-200
Closed -$2.86K 8104
2023
Q2
$2.86K Hold
200
﹤0.01% 6958
2023
Q1
$2.93K Sell
200
-3,100
-94% -$51.9K ﹤0.01% 6501
2022
Q4
$55.4K Sell
3,300
-34,200
-91% -$591K ﹤0.01% 4910
2022
Q3
$556K Sell
37,500
-36,900
-50% -$729K ﹤0.01% 3131
2022
Q2
$2.04M Sell
74,400
-90,600
-55% -$2.68M ﹤0.01% 2043
2022
Q1
$6.22M Buy
165,000
+12,200
+8% +$540K 0.01% 1361
2021
Q4
$9.49M Buy
152,800
+93,700
+159% +$7.1M 0.01% 1148
2021
Q3
$5.06M Sell
59,100
-50,800
-46% -$3.19M 0.01% 1678
2021
Q2
$6.8M Buy
109,900
+70,000
+175% +$3.56M 0.01% 1410
2021
Q1
$1.95M Buy
+39,900
New +$1.93M ﹤0.01% 2497
2020
Q3
Sell
-19,700
Closed -$257K 6419
2020
Q2
$257K Sell
19,700
-70,300
-78% -$764K ﹤0.01% 3175
2020
Q1
$815K Buy
90,000
+79,600
+765% +$755K 0.01% 1685
2019
Q4
$107K Buy
+10,400
New +$118K ﹤0.01% 3595

Other funds holding OPRX

Group One Trading's OPRX Position: Q2 2026 in Review

Group One Trading sold out of OptimizeRx (OPRX) in Q2 2026, closing a stake of 1,284 shares — an estimated $7.38K sold.

Group One Trading first reported a position in OPRX in Q4 2019 and held it in 11 quarters. The position peaked at $3.39M in Q1 2022. 112 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

  • Group One Trading reported no remaining OptimizeRx position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 1,284 OptimizeRx shares in Q2 2026, an estimated $7.38K.
  • Group One Trading first reported a position in OptimizeRx in Q4 2019 and held it in 11 quarters.
  • Group One Trading's OptimizeRx position peaked at $3.39M in Q1 2022.
  • 112 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.